Orthocell has announced that its Remplir™ nerve repair device has been used in 23 surgical procedures on injured soldiers in Ukraine.
Following a humanitarian delivery of Remplir to Ukraine in April 2025, Orthocell has now received confirmation that the device has been successfully utilised by Ukrainian surgeons in both primary and secondary nerve repair procedures.
Orthocell has now received confirmation that the device has been used by Ukrainian surgeons in both primary and secondary nerve repair procedures. Surgeons were trained remotely via video, supported by Australian Orthopaedic Surgeon and Orthocell Key Opinion Leader Dr Alex O’Beirne, demonstrating the accessibility and ease of adoption of the technology even in challenging clinical settings. Orthocell will continue working with Ukrainian clinicians to monitor patient outcomes and, where possible, collect clinical data to support engagement with defence organisations globally. Orthocell Managing Director Paul Anderson said: “In a time where there are multiple global conflicts, the application of Remplir in trauma-related nerve injuries is highly relevant. The successful remote training of surgeons and subsequent use of the device across 23 patients reinforces its unique handling, transportability, and clinical utility as a leading collagen-based nerve repair solution.” Click to read the ASX release.